Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter van Paassen

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Nephron|March 15, 2019
Mother and Child Reunion in "Hypertensive" End-Stage Renal Disease: Will They Complement Each Other?Sjoerd A M E G Timmermans, Pieter van Paassen,
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 12, 2009
Influenza vaccination in ANCA-associated vasculitisBart Spaetgens, Pieter van Paassen, Jan Willem Cohen Tervaert
Kidney International|June 26, 2017
The Authors ReplySjoerd A M E G Timmermans, Pieter van Paassen,
The New England Journal of Medicine|December 8, 2009
Case 27-2009: A woman with fever, rash, and lymphadenopathyJudith Potjewijd, Pieter van Paassen, Jan Willem Cohen Tervaert
Best Practice & Research. Clinical Rheumatology|June 6, 2003
Laboratory assessment in musculoskeletal disordersPieter van Paassen, Jan Damoiseaux, Jan Willem Cohen Tervaert
Kidney International|August 26, 2018
Conservative treatment for C3 glomerulopathy and monoclonal IgSjoerd A M E G Timmermans, Pieter van Paassen,
Journal of the American Society of Nephrology : JASN|May 10, 2015
Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA VasculitisMarc Hilhorst, Pieter van Paassen, Jan Willem Cohen Tervaert, et al.
Journal of Clinical Medicine|July 24, 2021
The Syndromes of Thrombotic Microangiopathy: A Critical Appraisal on Complement DysregulationSjoerd A M E G Timmermans, Pieter van Paassen
Kidney International|December 15, 2010
New pathophysiological insights and treatment of ANCA-associated vasculitisBenjamin Wilde, Pieter van Paassen, Oliver Witzke, et al.
Annals of the Rheumatic Diseases|September 21, 2007
Clinical manifestations of the anti-phospholipid syndrome as defined by the updated Sapporo classification criteriaJesse Drijkoningen, Jan Damoiseaux, Pieter van Paassen, et al.
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Nephron|March 15, 2019
Mother and Child Reunion in "Hypertensive" End-Stage Renal Disease: Will They Complement Each Other?Sjoerd A M E G Timmermans, Pieter van Paassen,
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 12, 2009
Influenza vaccination in ANCA-associated vasculitisBart Spaetgens, Pieter van Paassen, Jan Willem Cohen Tervaert
Kidney International|June 26, 2017
The Authors ReplySjoerd A M E G Timmermans, Pieter van Paassen,
The New England Journal of Medicine|December 8, 2009
Case 27-2009: A woman with fever, rash, and lymphadenopathyJudith Potjewijd, Pieter van Paassen, Jan Willem Cohen Tervaert
Best Practice & Research. Clinical Rheumatology|June 6, 2003
Laboratory assessment in musculoskeletal disordersPieter van Paassen, Jan Damoiseaux, Jan Willem Cohen Tervaert
Kidney International|August 26, 2018
Conservative treatment for C3 glomerulopathy and monoclonal IgSjoerd A M E G Timmermans, Pieter van Paassen,
Journal of the American Society of Nephrology : JASN|May 10, 2015
Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA VasculitisMarc Hilhorst, Pieter van Paassen, Jan Willem Cohen Tervaert, et al.
Journal of Clinical Medicine|July 24, 2021
The Syndromes of Thrombotic Microangiopathy: A Critical Appraisal on Complement DysregulationSjoerd A M E G Timmermans, Pieter van Paassen
Kidney International|December 15, 2010
New pathophysiological insights and treatment of ANCA-associated vasculitisBenjamin Wilde, Pieter van Paassen, Oliver Witzke, et al.
Annals of the Rheumatic Diseases|September 21, 2007
Clinical manifestations of the anti-phospholipid syndrome as defined by the updated Sapporo classification criteriaJesse Drijkoningen, Jan Damoiseaux, Pieter van Paassen, et al.
Pageof 14